ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Synapse Biomedical Receives FDA Emergency Use Authorization for New System to Assist in Weaning Patients off of Ventilators During COVID-19 Pandemic
April 15, 2020Synapse Biomedical, Inc. has received FDA Emergency Use Authorization for the emergency use of its TransAeris® DPS, to assist in weaning patients determined by their healthcare provider to be at high risk of weaning failure off of ventilators in healthcar
Pharma Sources Insight January 2025
